Home NDC 16729-151 topotecan hydrochloride
Product NDC 16729-151
11-digit product format 167290151
Labeler code 16729
Product ID 16729-151_23a75b4a-a836-a01d-e063-6394a90a67b3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name topotecan hydrochloride
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Accord Healthcare, Inc.
Application ANDA202351
Marketing category ANDA
Marketing start 2013-07-23
Substance TOPOTECAN HYDROCHLORIDE
Active strength 4 mg/4mL
Pharmacologic classes Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202351-001 TOPOTECAN HYDROCHLORIDE TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A202351-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A202351-001 TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP 2013-06-26 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base topotecan hydrochloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TOPOTECAN HYDROCHLORIDE 4 mg/4mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 956S425ZCY Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1799416 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 16729-151-31 topotecan hydrochloride 1 in 1 PACKAGE INJECTION, POWDER, LYOPHILIZED, 1 10 16729-151-31 topotecan hydrochloride 4 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 4 10
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded TOPOTECAN HYDROCHLORIDE ACTIVE INGREDIENT 956S425ZCY TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 6 TOPOTECAN ACTIVE MOIETY 7M7YKX2N15 TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 6 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 6 MANNITOL INACTIVE INGREDIENT 3OWL53L36A TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 6 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 6 TARTARIC ACID INACTIVE INGREDIENT W4888I119H TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 16729-151 TOPOTECAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE, INC.] 10 Current NDC, Legacy NDC, 2 package rows 20241006_729b2b22-1344-44f3-b614-14f6ec3c263e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 16729-151-31 16729015131 1 VIAL in 1 PACKAGE (16729-151-31) / 4 mL in 1 VIAL 1 vial 2013-07-23 0000-00-00 No No Current